Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial.
Jung Min AhnSeung-Jung ParkSung-Cheol YunSeung Ho HurHun-Jun ParkDamras TresukosolWoong Cheol KangHyuck Moon KwonSeung-Woon RhaDo-Sun LimMyung Ho JeongBong-Ki LeeHe HuangYoung Hyo LimJang Ho BaeByung Ok KimTiong Kiam OngSung Gyun AhnCheol-Hyun ChungDuck-Woo ParkSeung Jung Parknull nullPublished in: Circulation (2022)
gov; Unique identifiers: NCT05125367 and NCT00997828.
Keyphrases
- phase iii
- coronary artery bypass
- double blind
- coronary artery disease
- percutaneous coronary intervention
- phase ii
- coronary artery bypass grafting
- placebo controlled
- open label
- clinical trial
- minimally invasive
- study protocol
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute coronary syndrome
- cardiovascular events
- cross sectional
- adipose tissue
- surgical site infection
- heart failure
- randomized controlled trial
- type diabetes
- skeletal muscle
- aortic stenosis
- left ventricular
- glycemic control